CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 529 enrolled
Drug / intervention
Screening for HCV in PWID and Linkage-To-Careother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02971488
NCT02971488N/ACompleted
CompareCT.gov

The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID

Hospital Universitario Infanta Leonor·observational·Posted Nov 23, 2016·Updated Sep 13, 2019

In Brief

An observational study evaluating Screening for HCV in PWID and Linkage-To-Care for Hepatitis C and 3 related conditions. Completed, enrolled 529 participants.

Detailed Summary

Screening, diagnosis and treatment of HCV in PWID, should be part of a harm reduction strategy. Treatment of HCV infected PWID should be delivered in a multidisciplinary care setting with services to reduce the risk of reinfection and for management of the common social and psychiatric comorbidities in this population. More frequent diagnosis, new methods that prevent loss of tracking, and access to antiviral treatment are all strategies that must be implemented jointly if the prevalence of HCV infection in our setting is to be reduced.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHepatitis C, Drug Users, Harm Reduction, HIV
Countries--
CollaboratorsInstituto de Salud Carlos III, Fundacion SEIMC-GESIDA

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 23, 2016
Enrollment StartJan 15, 2017
Primary CompletionDec 31, 2018
Study CompletionMay 10, 2019
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 9.6 years ago

Interventions

Screening for HCV in PWID and Linkage-To-Careother

Screening, diagnosis and treatment of HCV in PWID, will be part of a harm reduction strategy. Treatment of HCV infected PWID will be delivered in a multidisciplinary care setting with services to reduce the risk of reinfection and for management of the common social and psychiatric comorbidities in this population.